| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTB
|
actin, beta
|
|
ADORA2A
|
adenosine A2a receptor
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ANLN
|
anillin, actin binding protein
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATAD3B
|
ATPase family, AAA domain containing 3B
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTF3
|
basic transcription factor 3
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK11A
|
cyclin-dependent kinase 11A
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLOCK
|
clock circadian regulator
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EP300
|
E1A binding protein p300
|
|
EPHB4
|
EPH receptor B4
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FN1
|
fibronectin 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXE1
|
forkhead box E1
|
|
FOXH1
|
forkhead box H1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
GATA3
|
GATA binding protein 3
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXB13
|
homeobox B13
|
|
HOXC6
|
homeobox C6
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL6
|
interleukin 6
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM4B
|
lysine (K)-specific demethylase 4B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1324
|
KIAA1324
|
|
KISS1R
|
KISS1 receptor
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
LEP
|
leptin
|
|
LIF
|
leukemia inhibitory factor
|
|
LINC00312
|
long intergenic non-protein coding RNA 312
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MED14
|
mediator complex subunit 14
|
|
MED25
|
mediator complex subunit 25
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MIR130A
|
microRNA 130a
|
|
MIR145
|
microRNA 145
|
|
MIR152
|
microRNA 152
|
|
MIR18A
|
microRNA 18a
|
|
MIR18B
|
microRNA 18b
|
|
MIR190A
|
microRNA 190a
|
|
MIR193B
|
microRNA 193b
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR206
|
microRNA 206
|
|
MIR22
|
microRNA 22
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR27A
|
microRNA 27a
|
|
MIR302C
|
microRNA 302c
|
|
MIR375
|
microRNA 375
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT-CYB
|
cytochrome b
|
|
MTA2
|
metastasis associated 1 family, member 2
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NPPA
|
natriuretic peptide A
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NTS
|
neurotensin
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OLFM4
|
olfactomedin 4
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
PDZK1
|
PDZ domain containing 1
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER2
|
period circadian clock 2
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PITX1
|
paired-like homeodomain 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRB2
|
proline-rich protein BstNI subfamily 2
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRLR
|
prolactin receptor
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT2
|
protein arginine methyltransferase 2
|
|
PRMT6
|
protein arginine methyltransferase 6
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PUS1
|
pseudouridylate synthase 1
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RNF4
|
ring finger protein 4
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
SAFB
|
scaffold attachment factor B
|
|
SAFB2
|
scaffold attachment factor B2
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SDC2
|
syndecan 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFN
|
stratifin
|
|
SFR1
|
SWI5-dependent recombination repair 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SP4
|
Sp4 transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
TBK1
|
TANK-binding kinase 1
|
|
TCF20
|
transcription factor 20 (AR1)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZBTB10
|
zinc finger and BTB domain containing 10
|
|
ZBTB35
|
zinc finger and BTB domain containing 35
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF703
|
zinc finger protein 703
|